The human promyelocytic leukemia zinc finger gene is regulated by the Evi-1 oncoprotein and a novel guanine-rich site binding protein
Open Access
- 30 August 2002
- journal article
- Published by Springer Nature in Leukemia
- Vol. 16 (9) , 1755-1762
- https://doi.org/10.1038/sj.leu.2402682
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- AML-1/ETO fusion protein is a dominant negative inhibitor of transcriptional repression by the promyelocytic leukemia zinc finger proteinBlood, 2000
- Two Critical Hits for Promyelocytic LeukemiaMolecular Cell, 2000
- Cloning of a Coproporphyrinogen Oxidase Promoter Regulatory Element Binding ProteinBiochemical and Biophysical Research Communications, 2000
- Genomic sequence, structural organization, molecular evolution, and aberrant rearrangement of promyelocytic leukemia zinc finger geneProceedings of the National Academy of Sciences, 1999
- Leukemia translocation protein PLZF inhibits cell growth and expression of cyclin AOncogene, 1999
- Differential Regulation of Coproporphyrinogen Oxidase Gene Between Erythroid and Nonerythroid CellsBlood, 1998
- The Promyelocytic Leukemia Zinc Finger Protein Affects Myeloid Cell Growth, Differentiation, and ApoptosisMolecular and Cellular Biology, 1998
- Leukemia-associated retinoic acid receptor α fusion partners, PML and PLZF, heterodimerize and colocalize to nuclear bodiesProceedings of the National Academy of Sciences, 1997
- Production of high-titer helper-free retroviruses by transient transfection.Proceedings of the National Academy of Sciences, 1993
- Dissociation of c-fos induction from macrophage differentiation in human myeloid leukemic cell lines.Molecular and Cellular Biology, 1987